薬剤による臓β細胞再生:細胞治療標的へのアプローチ
Parinaz Parsi1, Saber Saharkhiz2, Marzieh Ramezani Farani3
1Bioinformatics Lab, Department of Biology, School of Sciences, Razi University, Kermanshah, Iran.
Cell regeneration (London, England)
|September 5, 2025
まとめ
研究者たちは 糖尿病の治療に不可欠な 臓のベータ細胞を再生する 新しい方法を模索しています このレビューは,ベータ細胞の増殖を促進し,糖尿病と闘うための小分子,受容体経路,および幹細胞療法をカバーしています.
科学分野:
- 内分泌学と代謝
- 再生医療
- 薬理学について
背景:
- 糖尿病は,全身の代謝疾患で, 臓のベータ細胞の障害による高血糖によって特徴付けられています.
- 1型糖尿病と2型糖尿病の両方では,ベータ細胞の機能不全または喪失が起こり,インスリン分泌が不十分になります.
- 増殖を通してベータ細胞の質を回復することは,糖尿病の重要な治療戦略です.
研究 の 目的:
- 臓のベータ細胞再生を促進する薬とメカニズムを見直す.
- 糖尿病の治療におけるベータ細胞増殖の改善のための治療標的を強調する.
- ベータ細胞修復のための代替戦略を探求する.
主な方法:
- ベータ細胞再生に関する科学文献のレビュー
- 細胞経路を標的とする小分子 (例えば,DYRK1A,アデノシンキナーゼ) の分析.
- 受容体媒介経路 (TGF-β,EGF,GLP-1など) と幹細胞治療の検討
主要な成果:
- ベータ細胞増殖に影響を与えるいくつかの小さな分子と受容体の経路が特定されています.
- ベータ細胞再生のための薬剤誘導標的は研究から明らかになっています.
- 幹細胞ベースの臨床試験では 糖尿病の治療法を積極的に研究しています
結論:
- 特定の細胞経路と受容体をターゲットにすると ベータ細胞再生の可能性が生まれます
- 幹細胞治療は 糖尿病管理の有望な手段です
- 薬物誘導標的に関するさらなる研究はベータ細胞再生戦略を前進させることができます.
関連する概念動画
Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Insulin: Biosynthesis, Chemistry, and Preparation
516
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
516
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K


